Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: bottomfish who wrote (54058)	7/10/2000 11:34:24 PM
From: Jim Bishop	Respond to of 150070

bf, those are questions that I don't think can be answered by any of us here. We'll have to wait for more news, or a filing....or you could try calling the following: Scientific Inquiries: DNAPrint genomics Inc., Sarasota Tony Frudakis, 941/351-4543 or Investor Inquiries: Catalyst Communications Inc., Sarasota Richard Craig Hall, 941/341-0136 From the website: dnaprint.com "By partnering our platform with biotech/pharma, we will participate in the downstream profits generated from pharmaceutical products our platform has enabled." "Our model is to license/partner our platform to generate 21st century medicines, and enable personalized medical analysis. We will do this through a combination of license/partnerships, hardware and software placement and application service provider (ASP) based models." "Pharmacogenomics is currently a 1 billion dollar industry and is projected to be a 10 billion dollar industry by the end of 2003. Several billions of dollars have been spent on the human genome project so far, and an equal amount will likely be spent trying to understand what all o the genomics information means (i.e. bioinformatics, proteomics and phenomics). Genomics is a multi billion dollar industry world-wide and the market for personalized medicine is expected to exceed $25 billion dollars by 2010. Recently congress has approved a $2.3 billion increase in NIH funding to a total of $18 billion dollars for the year 2000."